메뉴 건너뛰기




Volumn 93, Issue 3, 2008, Pages 93-97

Atopic eczema in children, NICE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CONTACT ALLERGEN; CORTICOSTEROID; EMOLLIENT AGENT; FLUCLOXACILLIN; FOOD ALLERGEN; PIMECROLIMUS; TACROLIMUS; DERMATOLOGICAL AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST;

EID: 46449114467     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (25)

References (9)
  • 1
    • 47849108094 scopus 로고    scopus 로고
    • Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years. National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Health and Clinical Excellence. RCOG Press, December 2007.
    • Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years. National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Health and Clinical Excellence. RCOG Press, December 2007.
  • 2
    • 47849116549 scopus 로고    scopus 로고
    • The Primary Care Dermatology Society and the British Association of Dermatologists. Guidelines for the management of atopic eczema. eGuidelines 2006;28:372-5. Available at http://www.eGuidelines.co. uk/ (accessed 3 Jan 2008).
    • The Primary Care Dermatology Society and the British Association of Dermatologists. Guidelines for the management of atopic eczema. eGuidelines 2006;28:372-5. Available at http://www.eGuidelines.co. uk/ (accessed 3 Jan 2008).
  • 3
    • 47849127508 scopus 로고    scopus 로고
    • Frequency of application of topical corticosteroids for atopic eczema
    • National Institute for Health and Clinical Excellence
    • National Institute for Health and Clinical Excellence. Frequency of application of topical corticosteroids for atopic eczema. NICE technology appraisal guidance 81.
    • NICE technology appraisal guidance , vol.81
  • 4
    • 47849110728 scopus 로고    scopus 로고
    • Tacrolimus and pimecrolimus for atopic eczema
    • National Institute for Health and Clinical Excellence
    • National Institute for Health and Clinical Excellence. Tacrolimus and pimecrolimus for atopic eczema. NICE technology appraisal guidance 82.
    • NICE technology appraisal guidance , vol.82
  • 5
    • 47849128813 scopus 로고    scopus 로고
    • Herbal medicines: Advice to consumers
    • July 2006. Available at, accessed 7 April 2008
    • Medicines and Healthcare products Regulatory Agency. Herbal medicines: advice to consumers. MHRA, July 2006. Available at http://www.mhra.gov.uk/ (accessed 7 April 2008).
    • MHRA
  • 6
    • 47849130181 scopus 로고    scopus 로고
    • London: Pharmaceutical Press
    • BNF for Children 2007. London: Pharmaceutical Press, 2007.
    • (2007) BNF for Children 2007
  • 7
    • 35148834200 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of cow's milk allergy in infants
    • Vandenplas Y, Brueton M, Dupont C, et al. Guidelines for the diagnosis and management of cow's milk allergy in infants. Arch Dis Child 2007;92:902-8.
    • (2007) Arch Dis Child , vol.92 , pp. 902-908
    • Vandenplas, Y.1    Brueton, M.2    Dupont, C.3
  • 8
    • 0348029616 scopus 로고    scopus 로고
    • Oral evening primrose oil and borage oil for atopic eczema (protocol)
    • Schmidt K, Pittler MH, Wilson N, et al. Oral evening primrose oil and borage oil for atopic eczema (protocol). Cochrane Database Syst Rev 2003;(2).
    • (2003) Cochrane Database Syst Rev , Issue.2
    • Schmidt, K.1    Pittler, M.H.2    Wilson, N.3
  • 9
    • 0042783669 scopus 로고    scopus 로고
    • Withdrawal of Epogam and Efamast
    • Medicines and Healthcare products Regulatory Agency
    • Medicines and Healthcare products Regulatory Agency. Withdrawal of Epogam and Efamast. Current Problems in Pharmacovigilance 2002;28:12.
    • (2002) Current Problems in Pharmacovigilance , vol.28 , pp. 12


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.